Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model.
Chami
F
F
Faculté des Sciences, Fès Laboratoire de Biotechnologie, BP 1796, Atlas FES, Morocco.
Chami
N
N
Bennis
S
S
Trouillas
J
J
Remmal
A
A
D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use*; D002176:Candida albicans / Q000187:drug effects; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy / Q000473:pathology / Q000517:prevention & control*; D000081007:Cymenes; D005054:Eugenol / Q000627:therapeutic use*; D005260:Female; D016867:Immunocompromised Host; D008826:Microbial Sensitivity Tests; D039821:Monoterpenes / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar; D014621:Vagina / Q000382:microbiology / Q000473:pathology
D000935:Antifungal Agents; D000081007:Cymenes; D039821:Monoterpenes; D005054:Eugenol; C073316:carvacrol